Role of cytokines in the pathogenesis of anemia of chronic disease in rheumatoid arthritis

Clinical Immunology

Volumn 92, Issue 2, 1999, Pages 153-160

  Voulgari, P V ^a   Kolios, G ^b   Papadopoulos, G K ^a   Katsaraki, A ^a   Seferiadis, K ^b   Drosos, A A ^a  

^a UNIVERSITY OF IOANNINA   (Greece)

^b UNIVERSITY HOSPITAL OF IOANNINA   (Greece)

Author keywords

Anemia of chronic disease; Cytokines; Rheumatoid arthritis

Indexed keywords

INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ANEMIA; ARTICLE; BURST FORMING UNIT E; COLONY FORMING UNIT E; CYTOKINE PRODUCTION; CYTOKINE RELEASE; ERYTHROPOIESIS; FEMALE; GROWTH INHIBITION; HUMAN; IMMUNOPATHOGENESIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS;

EID: 0032805582     PISSN: 15216616     EISSN: None     Source Type: Journal    
DOI: 10.1006/clim.1999.4736     Document Type: Article

References (46)

1. Ziff M. Rheumatoid arthritis - Its present and future. J. Rheumatol. 17:1990;127-133.
2. Baer Alan N., Dessypris E. N., Krantz S. B. The pathogenesis of anemia in rheumatoid arthritis: A clinical and laboratory analysis. Semin. Arthritis Rheum. 4:1990;209-223.
3. Sewell K. L., Trentham D. E. Pathogenesis of rheumatoid arthritis. Lancet. 341:1993;283-286.
4. Majed O. Short analytical review. Clin. Immunol. Immunopathol. 2:1997;103-116.
5. Tetta C., Camussi G., Modena V., Vittorio C. D., Baglioni C. Tumor necrosis factor in serum and synovial fluid of patients with active and severe rheumatoid arthritis. Ann. Rheum. Dis. 49:1990;665-667.
6. Eastgate J. A. Correlation of plasma interleukin 1 levels with disease activity in rheumatoid arthritis. Lancet. II:1988;706-709.
7. Houssiau F. A., Devogelaer J. P., van Damme J., Nagant de Deuxchaisnes C., van Snick J. Interleukin-6 in synovial fluid and serum of patients with rheumatoid arthritis and other inflammatory arthritides. Arthritis Rheum. 31:1988;784-788.
8. Feldmann M., Brennan F. M., Maini R. N. Rheumatoid arthritis. Cell. 85:1996;307-310.
9. Moutsopoulos H. M. Antibodies to cellular antigens in Greek patients with autoimmune rheumatic diseases: Anti-Ro(SSA) antibody a possible marker of penicillamine-D intolerance. Ann. Rheum. Dis. 43:1984;285-287.
10. Moutsopoulos H. M. Anti-Ro(SSA) positive rheumatoid arthritis (RA): A clinico-serological group of patients with high incidence of D-penicillamine side effects. Ann. Rheum. Dis. 44:1985;215-219.
11. Drosos A. A., Lanchbury J. S., Panayi G. S., Moutsopoulos H. M. Rheumatoid arthritis in Greek and British patients. Arthritis Rheum. 35:1992;745-748.
12. Papasteriades C. A. Lack of HLA antigen association in Greek rheumatoid arthritis patients. Rheumatol. Int. 5:1985;201-203.
13. Boki K. A. HLA class II sequence polymorphisms and susceptibility to rheumatoid arthritis in Greeks. Arthritis Rheum. 35:1992;749-755.
14. Boki K. A. Examination of HLA DR4 as a severity marker for rheumatoid arthritis in Greek patients. Ann. Rheum. Dis. 52:1993;517-519.
15. Drosos A. A., Moutsopoulos H. M. Rheumatoid arthritis in Greece: Clinical, serological and genetic considerations. Clin. Exp. Rheumatol. 13:1995;S7-S12.
16. Arnett F. C. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum. 31:1988;315-324.
17. Cecil. Wyngaarden J. B., Smith L. H. Jr. Textbook of Medicine. 1988;875 Saunders, Philadelphia.
18. Blake D. R., Waterworth R. F., Bacon P. A. Assessment of iron stores in inflammation by assay of serum ferritin concentrations. Br. Med. J. 283:1981;1147-1148.
19. Vreugdenhil G., Baltus C. A. M., van Eijk H. G., Swaak A. J. G. Anaemia of chronic disease: Diagnostic significance of erythrocyte and serological parameters in iron deficient rheumatoid arthritis patients. Br. J. Rheumatol. 29:1990;105-110.
20. Tzioufas A. G., Kokori S. I., Petrovas C. I., Moutsopoulos H. M. Autoantibodies to human recombinant erythropoietin in patients with systemic lupus erythematosus. Correlation with anemia. Arthritis Rheum. 40:1997;2212-2216.
21. Wintrobe M. M. Clinical Hematology. 1981;Lea & Febiger, Philadelphia.
22. Dayer J. M., Demczuk S. Cytokines and other mediators in rheumatoid arthritis. Springer Semin. Immunopathol. 7:1984;387-413.
23. Doube A., Davis M., Smith J. G., Maddison P. J., Collins A. J. Structured approach to the investigation of anaemia in patients with rheumatoid arthritis. Ann. Rheum. Dis. 51:1992;469-472.
24. Porter D. R., Sturrock R. D., Capell H. A. The use of serum ferritin estimation in the investigation of anaemia in patients with rheumatoid arthritis. Clin. Exp. Rheum. 12:1994;179-182.
25. Pincus T. Multicenter study of recombinant human erythropoietin in correction of anemia in rheumatoid arthritis. Am. J. Med. 89:1990;161-168.
26. Rodna E., Teresa M., Pascual E., Gibson T. Differences between Spanish and British patients in severity of rheumatoid arthritis: Comment on the article by Drosos. Arthritis Rheum. 37:1994;147-148.
27. Benazet, J. F., Reviron, D., Mercier, P., Roux, H., and Roudier, J., HLA-DRB1 alleles associated with rheumatoid arthritis in Southern France. Absence of extraarticular disease despite expression of the shared epitope. J. Rheumatol.22, 607-610, 1995.
28. Salvarani C. HLA-DRB1 alleles associated with rheumatoid arthritis in Northern Italy: Correlation with disease severity. Br. J. Rheumatol. 37:1998;165-169.
29. Jeffrey M. R. Some observations on anemia in rheumatoid arthritis. Blood. 8:1953;502-518.
30. Alvarez-Hernandez X., Liceaga J., McKay I. C., Brock J. H. Induction of hypoferremia and modulation of macrophage iron metabolism by tumor necrosis factor. Lab. Invest. 61:1989;319.
31. Broxmeyer H. E. The influence of purified, recombinant human heavy-subunit and light-subunit ferritins on colony formation in vitro by granulocyte-macrophage and erythroid progenitor cells. Blood. 68:1986;1257-1263.
32. Jongen-Lavrencic M., Peeters H. R. M., Vreugdenhil G., Swaak A. J. G. Interaction of inflammatory cytokines and erythropoietin in iron metabolism and erythropoiesis in anemia of chronic disease. Clin. Rheumatol. 5:1995;519-525.
33. Vreugdenhil G., Löwenberg B., Van Eijk H. G., Swaak A. J. G. Tumor necrosis factor alpha is associated with disease activity and the degree of anemia in patients with rheumatoid arthritis. Eur. J. Clin. Invest. 22:1992;488-493.
34. Roodman G. D., Bird A., Hutzler D., Montgomery W. Tumor necrosis factor-alpha and hematopoietic progenitors: Effects of tumor necrosis factor on the growth of erythroid progenitors CFU-E and BFU-E and the hematopoietic cell lines k562, HL60 and HEL cells. Exp. Hematol. 15:1987;928.
35. Broxmeyer H. E. The suppressive influences of tumor necrosis factors on bone marrow hematopoietic progenitor cells from normal donors and patients with leukemia: Synergism of tumor necrosis factor and interferon-γ J. Immunol. 136:1986;4487.
36. Katevas P. Peripheral blood mononuclear cells from patients with rheumatoid arthritis suppress erythropoiesis in vitro via the production of tumor necrosis factor alpha. Eur. J. Haematol. 53:1994;26-30.
37. Johnson C. S., Cook C. A., Furmanski P. In vivo suppression of erythropoiesis by tumor necrosis factor-α: Reversal with exogenous erythropoietin (epo). Exp. Hematol. 18:1990;109.
38. Jongen-Lavrencic M. Elevated levels of inflammatory cytokines in bone marrow of patients with rheumatoid arthritis and anemia of chronic disease. J. Rheumatol. 8:1997;1504-1508.
39. Rogers, J, Durmowicz, G, Kasschau, K, Lacroix, L, and, Bridges, K, A motif with the 5′ non-coding regions of acute phase mRNAs mediates ferritin translation by IL-1β and may contribute to the anemia of chronic disease, Blood, 367a, 78, 1991, (abstract).
40. Faquin W. C., Schneider T. J., Goldberg M. A. Effect of inflammatory cytokines on hypoxia-induced erythropoietin production. Blood. 79:1992;1987.
41. Maury C. P. J. Mechanism of anaemia in rheumatoid arthritis: Demonstration of raised interleukin-1 concentrations in anaemic patients and of interleukin-1 mediated suppression of normal erythropoiesis and proliferation of human erythroleukaemia (HEL) cells in vitro. Ann. Rheum. Dis. 47:1988;972-978.
42. Means R. T., Dessypris E. N., Krantz S. B. Inhibition of human erythroid colony-forming units by interleukin-1 is mediated by gamma interferon. J. Cell Physiol. 150:1992;59.
43. Vreugdenhil G., Löwenberg B., van Eijk H. G., Swaak A. J. G. Anemia of chronic disease in rheumatoid arthritis: Raised serum interleukin-6 (IL-6) levels and effects of IL-6 and anti-IL-6 on in vitro erythropoiesis. Rheumatol. Int. 10:1990;127-130.
44. Tanabe M. Remarkable elevation of interleukin 6 and interleukin 8 levels in the bone marrow serum of patients with rheumatoid arthritis. J. Rheumatol. 5:1994;830-835.
45. Lapadula G., Iannone F., Dell'Accio F., Covelli M., Pipitone V. Interleukin-10 in rheumatoid arthritis. Clin. Exp. Rheumatol. 13:1995;629-632.
46. Cush J. J. Elevated interleukin-10 levels in patients with rheumatoid arthritis. Arthritis Rheum. 38:1995;96-104.